Results
|
|
61.
|
|
|
|
62.
|
|
|
|
63.
|
|
|
|
64.
|
|
|
|
65.
|
|
|
|
66.
|
|
|
|
67.
|
|
|
|
68.
|
|
|
|
69.
|
|
|
|
70.
|
|
|
|
71.
|
|
|
|
72.
|
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. [electronic resource] by
- Morrow, S A
- O'Connor, P W
- Polman, C H
- Goodman, A D
- Kappos, L
- Lublin, F D
- Rudick, R A
- Jurgensen, S
- Paes, D
- Forrestal, F
- Benedict, R H B
Producer: 20110215
In:
Multiple sclerosis (Houndmills, Basingstoke, England) vol. 16
Availability: No items available.
|
|
|
73.
|
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. [electronic resource] by
- Ford, C
- Goodman, A D
- Johnson, K
- Kachuck, N
- Lindsey, J W
- Lisak, R
- Luzzio, C
- Myers, L
- Panitch, H
- Preiningerova, J
- Pruitt, A
- Rose, J
- Rus, H
- Wolinsky, J
Producer: 20100602
In:
Multiple sclerosis (Houndmills, Basingstoke, England) vol. 16
Availability: No items available.
|
|
|
74.
|
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study. [electronic resource] by
- Goodman, A D
- Rossman, H
- Bar-Or, A
- Miller, A
- Miller, D H
- Schmierer, K
- Lublin, F
- Khan, O
- Bormann, N M
- Yang, M
- Panzara, M A
- Sandrock, A W
Producer: 20090325
In:
Neurology vol. 72
Availability: No items available.
|
|
|
75.
|
Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial. [electronic resource] by
- Johnson, K P
- Brooks, B R
- Ford, C C
- Goodman, A D
- Lisak, R P
- Myers, L W
- Pruitt, A A
- Rizzo, M A
- Rose, J W
- Weiner, L P
- Wolinsky, J S
Producer: 20040226
In:
Multiple sclerosis (Houndmills, Basingstoke, England) vol. 9
Availability: No items available.
|
|
|
76.
|
Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy. [electronic resource] by
- Mock, D J
- Powers, J M
- Goodman, A D
- Blumenthal, S R
- Ergin, N
- Baker, J V
- Mattson, D H
- Assouline, J G
- Bergey, E J
- Chen, B
- Epstein, L G
- Blumberg, B M
Producer: 19991007
In:
Journal of neurovirology vol. 5
Availability: No items available.
|
|
|
77.
|
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS. [electronic resource] by
- Cohen, J A
- Cutter, G R
- Fischer, J S
- Goodman, A D
- Heidenreich, F R
- Kooijmans, M F
- Sandrock, A W
- Rudick, R A
- Simon, J H
- Simonian, N A
- Tsao, E C
- Whitaker, J N
Producer: 20021004
In:
Neurology vol. 59
Availability: No items available.
|
|
|
78.
|
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. [electronic resource] by
- Cohen, J A
- Cutter, G R
- Fischer, J S
- Goodman, A D
- Heidenreich, F R
- Jak, A J
- Kniker, J E
- Kooijmans, M F
- Lull, J M
- Sandrock, A W
- Simon, J H
- Simonian, N A
- Whitaker, J N
Producer: 20010705
In:
Archives of neurology vol. 58
Availability: No items available.
|
|
|
79.
|
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data. [electronic resource] by
- Cohen, J A
- Calabresi, P A
- Chakraborty, S
- Edwards, K R
- Eickenhorst, T
- Felton, W L
- Fisher, E
- Fox, R J
- Goodman, A D
- Hara-Cleaver, C
- Hutton, G J
- Imrey, P B
- Ivancic, D M
- Mandell, B F
- Perryman, J E
- Scott, T F
- Skaramagas, T T
- Zhang, H
Producer: 20080801
In:
Multiple sclerosis (Houndmills, Basingstoke, England) vol. 14
Availability: No items available.
|
|
|
80.
|
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS. [electronic resource] by
- Cohen, J A
- Imrey, P B
- Calabresi, P A
- Edwards, K R
- Eickenhorst, T
- Felton, W L
- Fisher, E
- Fox, R J
- Goodman, A D
- Hara-Cleaver, C
- Hutton, G J
- Mandell, B F
- Scott, T F
- Zhang, H
- Apperson-Hansen, C
- Beck, G J
- Houghtaling, P L
- Karafa, M T
- Stadtler, M
Producer: 20090316
In:
Neurology vol. 72
Availability: No items available.
|